Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Novartis Vaccines and Diagnostics S.r.l
Woman and Man Max 99 years
Novartis Vaccines and Diagnostics S.r.l
Update Il y a 4 ans
A Randomized, Single-blind, Dose-Ranging, Study to Evaluate Immunogenicity, Safety and Tolerability of Different Formulations of Adjuvanted and non Adjuvanted Cell-Derived, Inactivated Novel Swine Origin A/H1N1 Monovalent Subunit Influenza Virus Vaccine in Healthy Subjects 18 or More Years of Age
To identify the preferred vaccine formulation (with and without MF59), dosage (of antigen and adjuvant) and schedule (one or two administrations) of the cell-derived H1N1sw monovalent vaccine in healt...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Novartis Vaccines and Diagnostics S.r.l
Update Il y a 4 ans
A Randomized, Single-blind, Dose-Ranging Study to Evaluate Immunogenicity, Safety and Tolerability of Different Formulations of Adjuvanted and non Adjuvanted Cell-derived, Inactivated Novel Swine Origin A/H1N1 Monovalent Subunit Influenza Virus Vaccine in Healthy Subjects from 6 Months to 17 Years of Age
To identify the preferred vaccine formulation (with or without MF59), dosage (of antigen and adjuvant) and schedule (one or two administrations) of the cell-derived H1N1sw monovalent vaccine in health...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Novartis Vaccines and Diagnostics S.r.l
Update Il y a 4 ans
Clinical study to evaluate safety and antibodies response of flu vaccine FLUAD for 2012/2013 flu season. Studio clinico per la valutare la sicurezza e la risposta anticorpale del vaccino antinfluenzale FLUAD per la stagione influenzale 2012/2013
To evaluate the safety of a single intramuscular (IM) injection of Fluad in elderly subjects in compliance with the requirements of the current EU recommendations for clinical trials related to year...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Novartis Vaccines and Diagnostics S.r.l
Update Il y a 4 ans
A Phase II, Open Label, Uncontrolled, Multi Center Study to Evaluate Safety and Immunogenicity of AGRIPPAL S1® Surface Antigen, Inactivated, Influenza Vaccine, Formulation 2007-2008, when Administered to Non-Elderly Adult and Elderly Subjects
To evaluate the antibody response to each influenza vaccine antigen, as measured by Single Radial Hemolysis (SRH) at 21 days post-vaccination in non-elderly adult and elderly subjects in compliance wi...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Novartis Vaccines and Diagnostics S.r.l
Update Il y a 4 ans
A Phase II Open Label, Uncontrolled, Multi Center Study to Evaluate Safety and Immunogenicity of a Surface, Antigen, Inactivated, Adjuvanted with MF59C.1 Influenza Vaccine (Fluad), Formulation 2011/2012, when Administered to elderly subjects
To evaluate the safety of a single intramuscular (IM) injection of Fluad in elderly subjects in compliance with the requirements of the current EU recommendations for clinical trials related to yearly...
Country
None
organs
None
Specialty
None
Closed trial
More information
Previous
2
3
4
5
6
7